BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/20/2025 7:38:46 AM | Browse: 31 | Download: 60
 |
Received |
|
2024-05-07 12:46 |
 |
Peer-Review Started |
|
2024-05-07 12:46 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2024-11-26 06:13 |
 |
Revised |
|
2024-12-01 10:59 |
 |
Second Decision |
|
2024-12-27 02:35 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2024-12-27 08:23 |
 |
Articles in Press |
|
2024-12-27 08:23 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2025-01-08 10:54 |
 |
Publish the Manuscript Online |
|
2025-01-20 07:38 |
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Infectious Diseases |
Manuscript Type |
Basic Study |
Article Title |
Mesalazine alleviated the symptoms of spontaneous colitis in interleukin-10 knockout mice by regulating the STAT3/NF-κB signaling pathway
|
Manuscript Source |
Invited Manuscript |
All Author List |
Qian Chen, Ya-Li Zhang, Yong-Quan Shi and Lie Zheng |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Xi’an Science and Technology Plan Project |
23YXYJ0162 |
Shaanxi Province Traditional Chinese Medicine Research and Innovation Talent Plan Project |
TZKN-CXRC-16 |
Project of Shaanxi Administration of Traditional Chinese Medicine |
SZY-KJCYC-2025-JC-010 |
Shaanxi Province Key Research and Development Plan Project-Social Development Field |
S2025-YF-YBSF-0391 |
the Science and Technology Innovation Cultivation Program of Longhua Hospital affiliated to Shanghai University of Chinese Medicine |
YD202220 |
|
Corresponding Author |
Lie Zheng, PhD, Department of Gastroenterology, Traditional Chinese Medicine Hospital of Shaanxi Province, No. 4 Xihuamen, Lianhu District, Xi’an 710003, Shaanxi Province, China. 492688049@qq.com |
Key Words |
Mesalazine; Ulcerative colitis; Interleukin-10-/- mice; Signal transducer and activator of transcription 3/nuclear factor kappa B signaling pathway; Endoplasmic reticulum stress; Inflammatory bowel disease |
Core Tip |
Long-term and persistent excessive endoplasmic reticulum stress in IL-10-/- mice intestinal epithelial cells destroy the intestinal mucosal barrier and activates the signal transducer and activator of transcription 3/nuclear factor kappa B pathway, leading to the spontaneous generation of ulcerative colitis. Mesalazine could alleviate the symptoms of colitis in IL-10-/- mice, regulate endoplasmic reticulum stress and down-regulate the signal transducer and activator of transcription 3/nuclear factor kappa B pathway. |
Publish Date |
2025-01-20 07:38 |
Citation |
<p>Chen Q, Zhang YL, Shi YQ, Zheng L. Mesalazine alleviated the symptoms of spontaneous colitis in interleukin-10 knockout mice by regulating the STAT3/NF-κB signaling pathway. <i>World J Gastroenterol</i> 2025; 31(7): 96459</p> |
URL |
https://www.wjgnet.com/1007-9327/full/v31/i7/96459.htm |
DOI |
https://dx.doi.org/10.3748/wjg.v31.i7.96459 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345